NCT05500391View on ClinicalTrials.gov

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

PHASE2RecruitingINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

February 28, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2029

Conditions
Stage I Testicular SeminomaStage I Testicular Nonseminomatous Germ Cell TumorGastrointestinal Stromal TumorsOvarian Germ Cell TumorAdenocarcinoma, Clear CellBorderline Ovarian TumorSex Cord-Stromal TumorMucinous Adenocarcinoma of OvaryCarcinoma, Small CellCarcinosarcoma, OvarianSerous Tumor of OvaryGliomaNeuroendocrine TumorsAggressive Fibromatosis of Abdominal Wall (Disorder)
Interventions
OTHER

Oncological Follow-up

Post-cancer surveillance (including biological, clinical and imaging exams depending on the condition)

Trial Locations (3)

14076

NOT_YET_RECRUITING

Centre François Baclesse, Caen

59020

RECRUITING

Centre Oscar Lambret, Lille

80054

NOT_YET_RECRUITING

CHU Amiens, Amiens

All Listed Sponsors
collaborator

Canceropôle Nord Ouest

OTHER

collaborator

Groupement Interrégional de Recherche Clinique et d'Innovation

OTHER

lead

Centre Oscar Lambret

OTHER